Profund Advisors’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-29,348
| Closed | -$212K | – | 1176 |
|
|
2024
Q3 | $212K | Buy |
29,348
+6,389
| +28% | +$46.1K | 0.01% | 1023 |
|
|
2024
Q2 | $249K | Sell |
22,959
-37,624
| -62% | -$409K | 0.01% | 840 |
|
|
2024
Q1 | $1.14M | Buy |
60,583
+10,870
| +22% | +$204K | 0.04% | 327 |
|
|
2023
Q4 | $1.08M | Sell |
49,713
-19,042
| -28% | -$413K | 0.05% | 310 |
|
|
2023
Q3 | $1.41M | Buy |
68,755
+43,076
| +168% | +$887K | 0.08% | 204 |
|
|
2023
Q2 | $1.21M | Sell |
25,679
-5,465
| -18% | -$257K | 0.06% | 276 |
|
|
2023
Q1 | $1.31M | Buy |
+31,144
| New | +$1.31M | 0.08% | 225 |
|
|
2020
Q3 | – | Sell |
-11,507
| Closed | -$478K | – | 1005 |
|
|
2020
Q2 | $478K | Buy |
11,507
+1,766
| +18% | +$73.4K | 0.03% | 412 |
|
|
2020
Q1 | $280K | Sell |
9,741
-3,547
| -27% | -$102K | 0.02% | 516 |
|
|
2019
Q4 | $959K | Buy |
13,288
+1,401
| +12% | +$101K | 0.04% | 360 |
|
|
2019
Q3 | $1.67M | Sell |
11,887
-713
| -6% | -$100K | 0.08% | 226 |
|
|
2019
Q2 | $2.31M | Sell |
12,600
-1,393
| -10% | -$255K | 0.11% | 171 |
|
|
2019
Q1 | $2.23M | Buy |
13,993
+1,127
| +9% | +$179K | 0.11% | 176 |
|
|
2018
Q4 | $1.23M | Sell |
12,866
-3,101
| -19% | -$297K | 0.08% | 244 |
|
|
2018
Q3 | $2.26M | Buy |
+15,967
| New | +$2.26M | 0.09% | 201 |
|